NovAccess Global Inc. (XSNX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 26, 2026, 4:00 PM EST
NovAccess Global Employees
NovAccess Global had 2 employees as of September 30, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$1,328,945
Market Cap
6.17K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2024 | 2 | -1 | -33.33% | 2 | 0 |
| Sep 30, 2023 | 3 | 1 | 50.00% | 3 | 0 |
| Sep 30, 2022 | 2 | 0 | - | 2 | 0 |
| Sep 30, 2021 | 2 | 0 | - | 2 | 0 |
| Sep 30, 2020 | 2 | 0 | - | 1 | 1 |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
NovAccess Global News
- 2 years ago - NovAccess Global files patent with Cedars-Sinai - TheFly
- 2 years ago - NovAccess Global Advisory on Annual Meeting of Shareholders - Accesswire
- 2 years ago - NovAccess Global announces license to advance immunotherapy platform - TheFly
- 2 years ago - NovAccess Global Announces New License to Advance its Immunotherapy Platform - Accesswire
- 2 years ago - NovAccess Global says financing transaction with Sumner remains pending - TheFly
- 2 years ago - NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders - Accesswire
- 2 years ago - NovAccess Global announces $10.7M financing - TheFly
- 2 years ago - NovAccess Global Announces $10.7 Million Financing - Accesswire